相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Highlighting the Potential Role of Exosomes as the Targeted Nanotherapeutic Carrier in Metastatic Breast Cancer
Alisha Khera et al.
CURRENT DRUG DELIVERY (2023)
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
Preetpal Kaur et al.
MOLECULAR NEUROBIOLOGY (2023)
Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers
Claire Bridel et al.
BRAIN (2022)
Emerging role of exosomes as biomarkers in cancer treatment and diagnosis
Niloofar Asadi Hanjani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Blood-Based Alzheimer's Biomarkers
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases
Artur Schumacher-Schuh et al.
FRONTIERS IN NEUROLOGY (2022)
New insights into the genetic etiology of Alzheimer's disease and related dementias
Celine Bellenguez et al.
NATURE GENETICS (2022)
Translational approaches to understanding resilience to Alzheimer's disease
Sarah M. Neuner et al.
TRENDS IN NEUROSCIENCES (2022)
Multi-Modal Neuroimaging Neural Network-Based Feature Detection for Diagnosis of Alzheimer's Disease
Xianglian Meng et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders
Hema Kumari Alajangi et al.
MOLECULAR BRAIN (2022)
Alzheimer’s disease detection from optimal EEG channels and Tunable Q-Wavelet Transform
Digambar Vithhalbuwa Puri et al.
Indonesian Journal of Electrical Engineering and Computer Science (2022)
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen et al.
LANCET NEUROLOGY (2022)
The β-Secretase BACE1 in Alzheimer's Disease
Harald Hampel et al.
BIOLOGICAL PSYCHIATRY (2021)
Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
Longfei Jia et al.
ALZHEIMERS & DEMENTIA (2021)
Interrelations of Alzheimer′s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation
Frederic Brosseron et al.
JOURNAL OF NEUROCHEMISTRY (2021)
The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer's disease continuum: A systematic review and meta-analysis with narrative synthesis
Si Qi Yoong et al.
AGEING RESEARCH REVIEWS (2021)
Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
Thomas K. Karikari et al.
ALZHEIMERS & DEMENTIA (2021)
The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis
Simran Rastogi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Aβ(1-38) peptide is a negative regulator of the Aβ(1-42) peptide implicated in Alzheimer disease progression
Maa O. Quartey et al.
SCIENTIFIC REPORTS (2021)
Serum d-serine levels are altered in early phases of Alzheimer's disease: towards a precocious biomarker
Luciano Piubelli et al.
TRANSLATIONAL PSYCHIATRY (2021)
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease
Pratishtha Chatterjee et al.
TRANSLATIONAL PSYCHIATRY (2021)
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
Carolina Alquezar et al.
FRONTIERS IN NEUROLOGY (2021)
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
Salvatore Spina et al.
BRAIN (2021)
A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG
Eduardo Perez-Valero et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research
Christina M. Moloney et al.
ALZHEIMERS & DEMENTIA (2021)
Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?
Rodolfo Ferrando et al.
FRONTIERS IN NEUROLOGY (2021)
Alzheimer disease
David S. Knopman et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
The role of vascular dementia associated genes in patients with Alzheimer's disease: A large case-control study in the Chinese population
Xuewen Xiao et al.
CNS NEUROSCIENCE & THERAPEUTICS (2021)
Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity
Maria Berrocal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois et al.
LANCET NEUROLOGY (2021)
Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery
Bing Bai et al.
MOLECULAR NEURODEGENERATION (2021)
Biomarkers for neurodegenerative diseases
Oskar Hansson
NATURE MEDICINE (2021)
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus
Brianne M. Bettcher et al.
NATURE REVIEWS NEUROLOGY (2021)
Developing the ATX(N) classification for use across the Alzheimer disease continuum
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2021)
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease
William T. Hu et al.
NATURE COMMUNICATIONS (2021)
Head-to-Head Comparison of 8 Plasma Amyloid-beta 42/40 Assays in Alzheimer Disease
Shorena Janelidze et al.
JAMA NEUROLOGY (2021)
Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2
Harrison Specht et al.
GENOME BIOLOGY (2021)
Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review
Kirsten E. J. Wesenhagen et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk (vol 51, 404, 2019)
Iris E. Jansen et al.
NATURE GENETICS (2020)
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
M. M. J. van den Berg et al.
PROGRESS IN NEUROBIOLOGY (2020)
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease
Marti Colom-Cadena et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead
Joel Simren et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis
Nidhi Puranik et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2020)
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease
Sun Ah Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
SPR enhanced DNA biosensor for sensitive detection of donkey meat adulteration
Maryam Mansouri et al.
FOOD CHEMISTRY (2020)
Applications of biosensors in Alzheimer's disease diagnosis
Lais Canniatti Brazaca et al.
TALANTA (2020)
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
Shorena Janelidze et al.
NATURE COMMUNICATIONS (2020)
Improving the resistance and resilience framework for aging and dementia studies
Eider M. Arenaza-Urquijo et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment
Weilin Liu et al.
TRANSLATIONAL PSYCHIATRY (2020)
CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges
Simon Hornung et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer's Disease
Syed Haris Omar et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Surface plasmon resonance biosensor for the detection of tau-amyloid β complex
Tomas Springer et al.
SENSORS AND ACTUATORS B-CHEMICAL (2020)
Early Detection and Prevention of Alzheimer's Disease: Role of Oxidative Markers and Natural Antioxidants
Jamshed Arslan et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Single-cell Proteomics: Progress and Prospects
Ryan T. Kelly
MOLECULAR & CELLULAR PROTEOMICS (2020)
Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases
Ilaria Genovese et al.
CELL DEATH & DISEASE (2020)
Association between plasma exosome neurogranin and brain structure in patients with Alzheimer's disease: a protocol study
MengFei He et al.
BMJ OPEN (2020)
Biomarkers for Alzheimer's Disease Early Diagnosis
Eva Auso et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease
Ida Manna et al.
PHARMACEUTICALS (2020)
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Niklas Mattsson-Carlgren et al.
NATURE COMMUNICATIONS (2020)
Correlations of apathy with clinical symptoms of Alzheimer's disease and olfactory dysfunctions: a cross-sectional study
Shu-yang Yu et al.
BMC NEUROLOGY (2020)
Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis
Aysa Rezabakhsh et al.
BIOSENSORS & BIOELECTRONICS (2020)
LassoNet: Deep Lasso-Selection of 3D Point Clouds
Zhutian Chen et al.
IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS (2020)
The role of brain structural magnetic resonance imaging in the assessment of hippocampal subfields in Alzheimer's disease
Sameh Hany Sobhy Saad et al.
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2020)
Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review
Jong-Chan Park et al.
BMB REPORTS (2020)
Biomarkers of Alzheimer Disease
Melissa M. Budelier et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patients
Andrea Ciarmiello et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Involvement of calpain in the neuropathogenesis of Alzheimer's disease
Yacoubou Abdoul Razak Mahaman et al.
MEDICINAL RESEARCH REVIEWS (2019)
A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent
Hanbi Kim et al.
ACS SENSORS (2019)
Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers
Carmen Pena-Bautista et al.
CLINICA CHIMICA ACTA (2019)
CLINICAL AND BIOMEDICAL APPLICATIONS OF SURFACE PLASMON RESONANCE SYSTEMS
David E. Meza-Sanchez et al.
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION (2019)
Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT study
Willem S. Eikelboom et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2019)
Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease
Liqun Jiang et al.
MEDICAL SCIENCE MONITOR (2019)
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers
Jinny Claire Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
α-synuclein in the pathophysiology of Alzheimer's disease
Daniel Twohig et al.
MOLECULAR NEURODEGENERATION (2019)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2019)
The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer's Disease-Review of Literature and Interesting Images
Subapriya Suppiah et al.
DIAGNOSTICS (2019)
A dream of single-cell proteomics
Vivien Marx
NATURE METHODS (2019)
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease
Michael Ewers et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI
Seyed Hani Hojjati et al.
FRONTIERS IN NEUROLOGY (2019)
M/EEG-Based Bio-Markers to Predict the MCI and Alzheimer's Disease: A Review From the ML Perspective
Su Yang et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2019)
An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β(1-42) using a microporous gold nanostructure
Masoud Negahdary et al.
MICROCHIMICA ACTA (2019)
New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds
Carmen Pena-Bautista et al.
SCIENTIFIC REPORTS (2019)
A combined miRNA-piRNA signature to detect Alzheimer's disease
Gaurav Jain et al.
TRANSLATIONAL PSYCHIATRY (2019)
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment
Patrick Oeckl et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
An Integrated View on Vascular Dysfunction in Alzheimer's Disease
Jan Klohs
NEURODEGENERATIVE DISEASES (2019)
Relationship Between DTI Metrics and Cognitive Function in Alzheimer's Disease
Chantel D. Mayo et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
Seung-Hoon Yang
INTERNATIONAL NEUROUROLOGY JOURNAL (2019)
What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review
Claire Tochel et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John L. Robinson et al.
BRAIN (2018)
Complexity Measures for Quantifying Changes in Electroencephalogram in Alzheimer's Disease
Ali H. Husseen Al-Nuaimi et al.
COMPLEXITY (2018)
Fuzzy Entropy Analysis of the Electroencephalogram in Patients with Alzheimer's Disease: Is the Method Superior to Sample Entropy?
Samantha Simons et al.
ENTROPY (2018)
Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection
Carmen Pena-Bautista et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease
Che-Chuan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Coupled Imaging with [F-18]FBB and [F-18]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain
Agostino Chiaravalloti et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Sex differences in Alzheimer disease - the gateway to precision medicine
Maria Teresa Ferretti et al.
NATURE REVIEWS NEUROLOGY (2018)
Resistance vs resilience to Alzheimer disease Clarifying terminology for preclinical studies
Eider M. Arenaza-Urquijo et al.
NEUROLOGY (2018)
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images
Donghuan Lu et al.
SCIENTIFIC REPORTS (2018)
GWAS on family history of Alzheimer's disease
Riccardo E. Marioni et al.
TRANSLATIONAL PSYCHIATRY (2018)
Application of Metabolomics in Alzheimer's Disease
Jordan Maximillian Wilkins et al.
FRONTIERS IN NEUROLOGY (2018)
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M. W. Verberk et al.
ANNALS OF NEUROLOGY (2018)
SPECT and PET imaging in Alzheimer's disease
Varvara Valotassiou et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
Bruno Becker et al.
MOLECULAR NEURODEGENERATION (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Imaging the evolution and pathophysiology of Alzheimer disease
William Jagust
NATURE REVIEWS NEUROSCIENCE (2018)
A Comprehensive Review of Magnetoencephalography (MEG) Studies for Brain Functionality in Healthy Aging and Alzheimer's Disease (AD)
Pravat K. Mandal et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2018)
The Role of Magnetoencephalography in the Early Stages of Alzheimer's Disease
David Lopez-Sanz et al.
FRONTIERS IN NEUROSCIENCE (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2018)
Alzheimer's disease and blood-based biomarkers - potential contexts of use
Martina Zverova
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease
Simone Lista et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease
Theresa A. Lusardi et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Scott E. Counts et al.
NEUROTHERAPEUTICS (2017)
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease
Simone Lista et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review
Louise Rice et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls
Aylin Yilmaz et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease
Yuki Kitamura et al.
NEUROLOGICAL RESEARCH (2017)
Hierarchical Sparse Modeling: A Choice of Two Group Lasso Formulations
Xiaohan Yan et al.
STATISTICAL SCIENCE (2017)
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
Jong-Chan Park et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Diagnosis of Alzheimer's Disease Based on Structural MRI Images Using a Regularized Extreme Learning Machine and PCA Features
Ramesh Kumar Lama et al.
JOURNAL OF HEALTHCARE ENGINEERING (2017)
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2017)
Relation of Plasma Selenium and Lipid Peroxidation End Products in Patients With Alzheimer's Disease
Z. Chmatalova et al.
PHYSIOLOGICAL RESEARCH (2017)
Resilience to Alzheimer's Disease: The Role of Physical Activity
Anna Pedrinolla et al.
CURRENT ALZHEIMER RESEARCH (2017)
Neuroinflammation, immune system and Alzheimer disease: searching for the missing link
F. Guerriero et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
Aiko Ishiki et al.
JOURNAL OF NEUROCHEMISTRY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
A Biologist's Field Guide to Multiplexed Quantitative Proteomics
Corey E. Bakalarski et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Increased CSF neurogranin concentration is specific to Alzheimer disease
Henrietta Wellington et al.
NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Imaging and machine learning techniques for diagnosis of Alzheimer's disease
Golrokh Mirzaei et al.
REVIEWS IN THE NEUROSCIENCES (2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
Annika Ohrfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Plasma β-amyloid in Alzheimer's disease and vascular disease
Shorena Janelidze et al.
SCIENTIFIC REPORTS (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Exploring Biomarkers for Alzheimer's Disease
Neeti Sharma et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2016)
Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease
Christoph Laske et al.
ALZHEIMERS & DEMENTIA (2015)
Innovative diagnostic tools for early detection of Alzheimer's disease
Christoph Laske et al.
ALZHEIMERS & DEMENTIA (2015)
Tau Protein Detection in Anosmic Alzheimer's Disease Patient's Nasal Secretions
G. C. Passali et al.
CHEMOSENSORY PERCEPTION (2015)
Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions
Joel Raskin et al.
CURRENT ALZHEIMER RESEARCH (2015)
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection
Stefan Teipel et al.
LANCET NEUROLOGY (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Structural imaging biomarkers of Alzheimer's disease: predicting disease progression
Simon F. Eskildsen et al.
NEUROBIOLOGY OF AGING (2015)
Plasma 8-isoPGF2α and serum melatonin levels in patients with minimal cognitive impairment and Alzheimer disease
Fevziye Burcu Sirin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2015)
Power spectral density and coherence analysis of Alzheimer's EEG
Ruofan Wang et al.
COGNITIVE NEURODYNAMICS (2015)
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment
L. Cheng et al.
MOLECULAR PSYCHIATRY (2015)
Recent advances in the application of metabolomics to Alzheimer's Disease
Eugenia Trushina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Developments in Tau PET Imaging
Eduardo Rigon Zimmer et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2014)
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Mirjana Babic et al.
CROATIAN MEDICAL JOURNAL (2014)
Tau PET Imaging in Alzheimer's Disease
Nobuyuki Okamura et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2014)
MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease
Julia Banzhaf-Strathmann et al.
EMBO JOURNAL (2014)
Early neuropsychological detection of Alzheimer's disease
C. Bastin et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2014)
A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review
Christopher M. Davison et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
Jochim Reinert et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Protein-Based Biomarkers in Cerebrospinal Fluid and Blood for Alzheimer's Disease
Yongyao Fu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics
Navin Rauniyar et al.
JOURNAL OF PROTEOME RESEARCH (2014)
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
Ann Brinkmalm et al.
MOLECULAR NEURODEGENERATION (2014)
MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid
Mareike Muller et al.
NEUROBIOLOGY OF AGING (2014)
Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations
Julio Acosta-Cabronero et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease
Ronald Lautner et al.
JAMA PSYCHIATRY (2014)
Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum
Kamalini G. Ranasinghe et al.
NEUROIMAGE-CLINICAL (2014)
Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain
Rukhsana Sultana et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease
R. Perneczky et al.
TRANSLATIONAL PSYCHIATRY (2013)
Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
S. Frost et al.
TRANSLATIONAL PSYCHIATRY (2013)
Alzheimer CSF biomarkers in routine clinical setting
F. Tabaraud et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value
Virginia Pérez et al.
Alzheimers & Dementia (2012)
Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG
Stephen F. Carter et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Magnetocardiography with a modular spin-exchange relaxation-free atomic magnetometer array
R. Wyllie et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
Metabolomic changes in autopsy-confirmed Alzheimer's disease
Rima Kaddurah-Daouk et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits
Fabio Di Domenico et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Michelle T. Fodero-Tavoletti et al.
BRAIN (2011)
Folate in smokers
Kenji Okumura et al.
CLINICA CHIMICA ACTA (2011)
Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1-42 aggregation and toxicity
Silvia Bolognin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
Advances in metal-induced oxidative stress and human disease
Klaudia Jomova et al.
TOXICOLOGY (2011)
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
John Q. Trojanowski et al.
ALZHEIMERS & DEMENTIA (2010)
The neurobiology of isoprostanes and Alzheimer's disease
Domenico Pratico
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Quantitative structural MRI for early detection of Alzheimer's disease
Linda K. McEvoy et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Sudha Seshadri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
ADP-Ribosylation of Brain Neuronal Proteins Is Altered by In Vitro and In Vivo Exposure to Inorganic Mercury
Pawel Palkiewicz et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
P. Lewczuk et al.
MOLECULAR PSYCHIATRY (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Role of structural MRI in Alzheimer's disease
Prashanthi Vemuri et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
PERSONS WITH ACQUIRED BRAIN INJURY AND MULTIPLE DISABILITIES ACCESS STIMULATION INDEPENDENTLY THROUGH MICROSWITCH-BASED TECHNOLOGY
Giulio E. Lancioni et al.
PERCEPTUAL AND MOTOR SKILLS (2010)
Automated Segmentation of Hippocampal Subfields From Ultra-High Resolution In Vivo MRI
Koen Van Leemput et al.
HIPPOCAMPUS (2009)
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
Kaj Blennow et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2008)
Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease
Christopher D. Aluise et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Independent generation of Aβ42 and Aβ38 peptide species by γ-secretase
Eva Czirr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Resting-state oscillatory brain dynamics in Alzheimer disease
Willem de Haan et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2008)
Approximate entropy and auto mutual information analysis of the electroencephalogram in Alzheimer's disease patients
D. Abasolo et al.
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING (2008)
Biomarkers for early detection of Alzheimer pathology
C. M. Clark et al.
NEUROSIGNALS (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Phosphorylation and cleavage of tau in non-AD tauopathies
Angela L. Guillozet-Bongaarts et al.
ACTA NEUROPATHOLOGICA (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
The significance of neuroinflammation in understanding Alzheimer's disease
P. Eikelenboom et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Quantitative magnetoencephalography of spontaneous brain activity in Alzheimer disease -: An exhaustive frequency analysis
Alberto Fernandez et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Lipids and the pathogenesis of Alzheimer's disease: Is there a link?
M. M. Mielke et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2006)
Promotion of oxidative lipid membrane damage by amyloid β proteins
IVJ Murray et al.
BIOCHEMISTRY (2005)
Analysis of regularity in the EEG background activity of Alzheimer's disease patients with Approximate Entropy
D Abásolo et al.
CLINICAL NEUROPHYSIOLOGY (2005)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Early event-related potential changes during working memory activation predict rapid decline in mild cognitive impairment
P Missonnier et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease
ZZ Chong et al.
PROGRESS IN NEUROBIOLOGY (2005)
Low dose mercury toxicity and human health
F Zahir et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2005)
Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease
DK Lahiri et al.
NEUROBIOLOGY OF AGING (2004)
The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint
RB Mani
STATISTICS IN MEDICINE (2004)
Lead poisoning
H Needleman
ANNUAL REVIEW OF MEDICINE (2004)
Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies
MD Devous
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease
KM Bradley et al.
BRITISH JOURNAL OF RADIOLOGY (2002)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease
EE Tuppo et al.
BRAIN RESEARCH BULLETIN (2001)
Role of phosphorylation in the conformation of τ peptides implicated in Alzheimer's disease
NL Daly et al.
BIOCHEMISTRY (2000)
Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study
HW Berendse et al.
CLINICAL NEUROPHYSIOLOGY (2000)